Related by context. All words. (Click for frequent words.) 80 FOLFIRI 79 5-FU/LV 79 plus dexamethasone 78 FOLFOX 77 dacarbazine 77 chlorambucil 76 Doxil ® 75 plus prednisone 75 carboplatin paclitaxel 75 placebo dexamethasone 75 clodronate 75 Fludara 75 mycophenolate mofetil 75 fluorouracil 74 dacarbazine DTIC 74 FOLFIRI alone 74 FOLFOX4 alone 74 chemoradiation therapy 74 XELOX 74 docetaxel chemotherapy 74 Flu Cy 74 Folfox 74 plus gemcitabine 74 5 Fluorouracil 74 standard chemotherapy regimen 73 octreotide LAR 73 sorafenib Nexavar 73 ACTEMRA TM 73 DOXIL 73 Peg IFN 73 mitoxantrone 73 preoperative chemotherapy 73 oral allopurinol 72 CIMZIA TM 72 achieved ACR# 72 gemcitabine chemotherapy 72 mCRC patients 72 adriamycin 72 FluCAM 72 azacitidine 72 pegylated interferon alfa 2b 72 4mg/kg 72 biochemical relapse 72 comparator arm 72 CIMZIA ™ 72 vinorelbine 72 KRAS mutations occur 72 pegylated interferon alpha 72 lopinavir r arm 72 zoledronic acid 72 lopinavir r 72 Pemetrexed 72 interferon ribavirin 72 infusional 5-FU/LV 72 metastatic GIST 72 infliximab monotherapy 72 docetaxel prednisone 72 Peginterferon 72 ZOLINZA 72 8mg/kg 72 daunorubicin 72 interferon alfa 2a 71 pegylated liposomal doxorubicin 71 decitabine 71 Elitek 71 Gemzar ® 71 oral clodronate 71 idraparinux 71 peginterferon alfa 2a 71 postoperative chemotherapy 71 unresectable stage 71 PREZISTA r 71 CR nPR 71 relapsed MM 71 alfa 2a 71 pemetrexed 71 peginterferon 71 ribavirin RBV 71 oblimersen 71 FOLFOX6 71 melphalan prednisone 71 amoxicillin clavulanate 71 Capecitabine 71 adjunctive placebo 71 ELOXATIN 71 Taxotere ® 71 sorafenib 71 imipenem 71 flutamide 71 iniparib 71 gemcitabine cisplatin 71 gemcitabine 71 interferon alfa 71 Gemcitabine 71 receiving prophylactic anticoagulation 71 oxycodone CR 71 neoadjuvant chemotherapy 71 anthracycline taxane 70 Irinotecan 70 5-fluorouracil/leucovorin 70 Navelbine ® 70 neurologic progression 70 azathioprine 70 titrated glipizide 70 TORISEL 70 complete cytogenetic response 70 ritonavir boosted 70 mapatumumab 70 tapentadol ER 70 idarubicin 70 ABVD 70 FUSILEV enhances 70 methotrexate monotherapy 70 fondaparinux 70 highly emetogenic 70 cisplatin vinorelbine 70 mcg QD 70 unfractionated heparin 70 temsirolimus 70 vandetanib 70 adalimumab 70 tiotropium 70 APTIVUS r 70 stage IIIb IV 70 telaprevir dosed 70 mitoxantrone plus 70 IFN alfa 70 estramustine 70 Bevacizumab 70 FOLPI 70 pamidronate 70 bevacizumab 70 chemotherapy gemcitabine 70 nicardipine 70 BENICAR HCT 70 NATRECOR R 70 gemcitabine carboplatin 70 neoadjuvant therapy 70 pegylated interferon alfa 70 Platinol ® 70 docetaxel Taxotere ® 70 cisplatin gemcitabine 70 5 FU leucovorin 70 5FU 70 Median PFS 70 VELCADE melphalan 70 chemoradiation 70 folinic acid 70 nab paclitaxel 70 prednisone prednisolone 69 salmeterol fluticasone 69 fluvastatin 69 TAXOTERE R 69 aspirin heparin 69 eribulin 69 tipranavir r 69 oral Hycamtin 69 topotecan 69 dalteparin 69 adjuvant radiation 69 low dose Iluvien 69 bortezomib 69 rosuvastatin #mg 69 receiving VICTRELIS 69 erlotinib Tarceva ® 69 oral rivaroxaban 69 bevacizumab Avastin 69 TTF Therapy 69 HER2 positive metastatic breast 69 #mg BID [001] 69 metastatic castration resistant 69 metastatic CRC 69 certolizumab 69 dacarbazine chemotherapy 69 pCR 69 sunitinib 69 TACE 69 CYPHER Stent 69 galiximab 69 locoregional 69 FIRMAGON 69 locoregional recurrence 69 bosentan 69 CANCIDAS 69 doripenem 69 squamous histology 69 ATACAND 69 chemotherapy docetaxel 69 Adjuvant chemotherapy 69 Zyclara 69 metastatic renal cell carcinoma 69 TLUS 69 nadroparin 69 docetaxel 69 LEXIVA r 69 paclitaxel carboplatin 69 gefitinib Iressa 69 sorafenib Nexavar ® 69 Navelbine 69 PREZISTA ritonavir 69 low dose cytarabine 69 abacavir lamivudine 69 mcg kg 69 sustained virologic response 69 pertuzumab 69 gefitinib 69 alteplase 69 DOXIL ® 69 lumbar spine BMD 69 NPH insulin 69 trastuzumab 69 mg ustekinumab 69 Paraplatin ® 69 LPV r 69 cabazitaxel 69 tenecteplase 69 prostate cancer HRPC 69 relapsed SCLC 69 rFVIIa 69 pegylated interferon alpha 2a 69 mRCC 69 nilotinib 69 Alkeran 68 bevacizumab Avastin ® 68 ULORIC 68 stage IIIB 68 dasatinib 68 abciximab 68 paclitaxel Taxol 68 Camptosar ® 68 ARB telmisartan 68 levosimendan 68 DMARDs 68 Kaplan Meier analysis 68 cyclophosphamide doxorubicin vincristine 68 Platinol ® cisplatin 68 DMARD 68 recurrent GBM 68 chemoembolization 68 adjuvant radiotherapy 68 ZYVOX 68 Pegylated Interferon 68 mg kg dose 68 dose cytarabine 68 thalidomide Thalomid 68 morphometric vertebral fractures 68 Jevtana 68 irbesartan 68 Ceplene/IL-2 68 achieved CCyR 68 tamsulosin 68 refractory NSCLC 68 mutated KRAS 68 rimonabant #mg 68 binary restenosis 68 steroid dexamethasone 68 ketorolac 68 goserelin 68 TAXUS Express Stent 68 Gliadel Wafer 68 lenalidomide Revlimid R 68 colesevelam HCl 68 mg/m2 dose 68 Median progression 68 severe exacerbations 68 eptifibatide 68 pegylated interferon alfa 2a 68 GnRH agonists 68 bendamustine 68 febrile neutropenia 68 Torisel 68 rizatriptan 68 efavirenz EFV 68 chemoradiotherapy 68 mg qd 68 peginterferon alfa 2a Pegasys 68 peg interferon 68 HBeAg positive patients 68 ximelagatran 68 darunavir ritonavir 68 GP IIb IIIa inhibitors 68 active comparator 68 FOLFIRINOX 68 fluticasone salmeterol 68 antithymocyte globulin 68 dasatinib Sprycel ® 68 lispro 68 azacytidine 68 IOP lowering 68 mg QD 68 tolvaptan 68 Neoadjuvant 68 gadobutrol 68 tirofiban 68 interferon alfa 2b 68 CHOP chemotherapy 68 underwent surgical resection 68 Hazard Ratio 68 mcg albinterferon alfa 2b 68 eplerenone 68 oxaliplatin Eloxatin 68 #.#mg/dL 68 ibandronate 68 colorectal cancer liver metastases 68 Free Survival PFS 68 mg BID 68 cetuximab Erbitux R 68 zoledronate 68 #mg dose [003] 68 cyclophosphamide methotrexate 68 dose dexamethasone 68 debulking surgery 68 CIMZIA TM certolizumab pegol 68 Aflibercept 68 low dose dexamethasone 68 cetuximab Erbitux ® 68 Xeloda ® 68 free survival PFS 68 placebo p = 68 ALND 68 everolimus eluting stents 68 invasive aspergillosis 68 KRAS wild 68 doxazosin 68 cisplatin chemotherapy 68 % CI #.#-#.# [003] 67 clopidogrel Plavix 67 EBRT 67 PREZISTA rtv 67 pomalidomide 67 XIENCE V PROMUS Stent 67 irinotecan chemotherapy 67 insulin detemir 67 ZACTIMA 67 tocilizumab 67 β blockers 67 PSADT 67 weekly subcutaneous injections 67 iniparib BSI 67 adjuvant chemotherapy 67 letrozole Femara 67 Tarceva TM 67 capecitabine 67 CCyR 67 Taxotere R 67 Hormone Refractory Prostate Cancer 67 Zometa hazard 67 candesartan cilexetil 67 partial remissions 67 DAPT 67 PegIFN RBV 67 paclitaxel chemotherapy 67 recurrent glioblastoma multiforme 67 VFEND 67 budesonide pMDI 67 RLAI 67 neoadjuvant 67 saline placebo 67 Platinol 67 palifermin 67 ritonavir boosted atazanavir 67 erlotinib 67 dexamethasone Decadron 67 progression TTP 67 gemcitabine Gemzar 67 Fluorouracil 67 peg IFN 67 receiving PEGINTRON 67 Thal Dex 67 doxorubicin HCl liposome injection 67 capecitabine Xeloda 67 plus methotrexate 67 KRAS mutant tumors 67 peginterferon alfa 2b 67 BARACLUDE ® 67 μg dose 67 unfractionated heparin UFH 67 concurrent chemoradiation 67 median PFS 67 severe neutropenia 67 plus ribavirin 67 aspirin clopidogrel 67 intravenous bisphosphonates 67 plus 5-FU/LV 67 trastuzumab Herceptin R 67 tipranavir 67 colorectal liver metastases 67 Pegasys ® 67 #mg/m# [002] 67 INTEGRILIN R 67 oral diclofenac 67 evaluating tivozanib 67 IV NSCLC 67 thromboembolic events 67 ARIMIDEX 67 PEGINTRON TM 67 anthracycline containing 67 metastatic RCC 67 Doxil 67 adjunctive ABILIFY 67 aldosterone antagonist 67 virologic failure 67 basiliximab 67 neostigmine 67 PASI scores 67 atorvastatin #mg 67 recurrent NSCLC 67 PREZISTA r arm 67 Velcade bortezomib 67 NATRECOR ® 67 5 fluorouracil 67 HBeAg negative patients 67 Targretin 67 NMIBC 67 biologic DMARD 67 docetaxel Taxotere 67 VaD 67 severe renal impairment 67 tenofovir emtricitabine 67 sunitinib Sutent 67 biochemical recurrence 67 cilostazol 67 Taxus Stent 67 relapsed myeloma 67 Halaven 67 fallopian tube carcinoma 67 relapsed CLL 67 Amrubicin 67 radiotherapy RT 67 fludarabine 67 visilizumab 67 angiographic restenosis 67 plus prednisone prednisolone 67 NEVO ™ 67 non squamous NSCLC 67 Xelox 67 Hycamtin ® 67 ertapenem 67 trabectedin 66 mitomycin 66 fluoropyrimidine 66 TNF antagonist 66 glargine 66 plus OBT 66 EFAPROXYN 66 temozolomide 66 Cyclophosphamide 66 paclitaxel eluting stents 66 imatinib therapy 66 #mg/day [002] 66 cetuximab 66 mcg kg REBETOL 66 alfuzosin 66 teriflunomide 66 metastatic malignant 66 tolterodine ER 66 adenoma recurrence 66 splenectomized patients 66 xanthine oxidase inhibitor 66 Bivalirudin 66 amphotericin B 66 posaconazole 66 platelet inhibitor 66 TPV r 66 TO AVOID PREGNANCY WHILE 66 Engerix B 66 3mg/kg 66 zalutumumab 66 #mg dose [001] 66 subcutaneous enoxaparin 66 tamoxifen Nolvadex ® 66 mcg BID 66 unresectable 66 reinfarction 66 postmenopausal osteoporotic women 66 dapagliflozin plus 66 iodixanol 66 Perforomist Inhalation Solution 66 bolus dose 66 hormone refractory metastatic prostate 66 heavily pretreated patients 66 voriconazole 66 advanced adenomas 66 leukemia AML 66 Median survival 66 gp# vaccine 66 relapsed multiple myeloma 66 abiraterone acetate 66 esomeprazole 66 Pegasys plus Copegus 66 discontinuations due 66 beclomethasone dipropionate 66 Pioglitazone 66 adalimumab Humira 66 imatinib 66 5 fluorouracil leucovorin 66 FROVA 66 glimepiride 66 ARIXTRA 66 deferoxamine 66 vincristine doxorubicin 66 BEACOPP 66 Erlotinib 66 microbiological eradication 66 HBeAg seroconversion 66 IFN α 66 YERVOY 66 epoetin beta 66 nadolol 66 cancer mCRC 66 recurrent VTE 66 epirubicin cyclophosphamide 66 Pegylated Liposomal Doxorubicin 66 moderate renal impairment 66 VAPRISOL 66 ACE Inhibitors 66 Taxol paclitaxel 66 leukopenia 66 PegIntron 66 cediranib 66 patients evaluable 66 standard chemotherapy regimens 66 Myelodysplastic Syndrome MDS 66 deep venous thromboses 66 FluCAM arm 66 epirubicin 66 FOLFOX regimen 66 rt PA 66 Bezielle 66 anthracyclines taxanes 66 COMBIVIR 66 dosage regimens 66 febuxostat 66 prostate cancer CRPC 66 refractory AML 66 gout flares 66 etanercept 66 neoadjuvant radiation 66 Cytoxan 66 INTELENCE 66 androgen deprivation 66 ABC/3TC 66 FASLODEX 66 clomipramine 66 fosamprenavir 66 metastatic lung cancer 66 oral ridaforolimus 66 annualized relapse 66 divalproex sodium 66 zidovudine lamivudine 66 nodular partial response 66 chemotherapy cisplatin 66 intravesical therapy 66 dutasteride 66 stable angina 66 urate lowering therapy 66 sustained virological response 66 chemotherapy FOLFOX 66 DMARDS 66 ALIMTA cisplatin 66 peginterferon alpha 2a 66 Fulvestrant 66 SVR# 66 PEGylated Fab fragment 66 Combination therapy 66 ARCOXIA 66 R# #mg BID 66 cyclophosphamide chemotherapy 66 etoposide 66 MAGE A3 ASCI 66 dexamethasone 66 aldosterone antagonists 66 entecavir 66 BUPHENYL R sodium phenylbutyrate 66 COZAAR 66 PRADAXA #mg 66 sirolimus eluting stent 66 TMP SMX 66 pioglitazone 66 fibrinolytic therapy 66 tamoxifen therapy 66 infusional 65 #mg/m# [001] 65 mg m² 65 FOLFOX chemotherapy 65 CALGB # [002] 65 ARCALYST ® 65 rHuEPO 65 zolmitriptan 65 ALA PDT 65 pegylated interferon peg IFN 65 doxorubicin docetaxel 65 mesalamine granules 65 stage IIIB IV 65 #mg doses [002] 65 oral levofloxacin 65 resected pancreatic cancer 65 imatinib Gleevec 65 mg simvastatin 65 MGd 65 INC# 65 Herceptin trastuzumab 65 primary hypercholesterolemia 65 Interferon alfa 65 degarelix 65 lung metastases 65 timolol 65 HCV RESPOND 2 65 receiving highly emetogenic 65 atazanavir ritonavir 65 cinacalcet 65 interferon therapy 65 pancreatic adenocarcinoma 65 tolterodine 65 biphasic insulin aspart 65 pimecrolimus 65 doxorubicin cyclophosphamide 65 candesartan 65 serum urate 65 AVASTIN 65 % Confidence Interval 65 cytogenetic response 65 GnRH agonist 65 TNF inhibitor 65 radioiodine therapy 65 radiochemotherapy 65 AVODART 65 MabCampath 65 alpha interferons 65 Fludarabine 65 oxycodone IR 65 Trastuzumab 65 cilengitide 65 achieved PASI 65 paclitaxel Taxol ® 65 bicalutamide 65 Natalizumab 65 cetuximab Erbitux 65 piperacillin tazobactam 65 PEGASYS ® 65 Decitabine 65 sunitinib malate 65 ziprasidone 65 lamivudine 65 INCB# [003] 65 IIIa inhibitor 65 alpha 2a 65 benazepril 65 axitinib 65 TELCYTA 65 superficial bladder cancer 65 alkylating agent 65 prednisone prednisolone plus 65 oral antidiabetic medication 65 Kepivance 65 PegIFN 65 Pegasys peginterferon alfa 2a 65 olmesartan 65 relapsed refractory multiple myeloma 65 abatacept 65 CR CRu 65 Relapsed Refractory Multiple Myeloma 65 adefovir 65 teriparatide 65 androgen suppression 65 ER CHOP 65 anastrozole 65 BENICAR 65 prior chemotherapy regimens 65 assessing T DM1 65 insulin glargine 65 HuMax EGFr 65 caspofungin 65 Dabigatran 65 Aptivus ® 65 #.#g/day 65 Ixempra 65 lamotrigine 65 Copegus ribavirin 65 enoxaparin 65 q#h 65 lapatinib Tykerb 65 PSA nadir 65 peginterferon alfa 65 corticosteroid therapy 65 solifenacin 65 OADs 65 nitroprusside 65 tumor shrinkage 65 carboplatin 65 amrubicin 65 QD dosing 65 corticosteroid dose 65 PEGylated anti 65 clopidogrel Plavix ® 65 endometrial hyperplasia 65 argatroban 65 lamivudine monotherapy 65 mg TID 65 CYPHER ® 65 Ophena TM 65 insulin glulisine 65 glufosfamide 65 antithrombotic therapy 65 ACR# response 65 irinotecan doxorubicin oxaliplatin paclitaxel 65 perioperatively 65 tacrolimus ointment 65 RECIST Response Evaluation Criteria 65 erlotinib Tarceva 65 interferon gamma 1b 65 chlorthalidone 65 anakinra 65 #mg QD [001] 65 paclitaxel cisplatin 65 vorinostat 65 icatibant 65 Ranibizumab 65 daily Infergen 65 P = .# 65 remission CR 65 bevacizumab Avastin R 65 paroxetine Paxil 65 fluorouracil leucovorin 65 panitumumab 65 fulvestrant 65 virologic response 65 Meets Primary Endpoint 65 KAPIDEX 65 underwent resection 65 EGFR TKI 65 #Gy 65 baseline HbA1c 65 taxotere 65 % CI #.#-#.# [007] 65 Taxotere docetaxel 65 Taxol ® 65 FEMALES SHOULD BE ADVISED 65 TMC# r 65 budesonide formoterol 65 metastatic HRPC 65 Dasatinib 65 paclitaxel Taxol R 65 alemtuzumab treated 65 p = NS 65 ribavirin therapy 65 exemestane 65 urinary N telopeptide 65 TNF antagonists 65 hA# 65 fenofibric acid 65 Peginterferon Alfa 2a 65 valsartan 65 aflibercept VEGF Trap 65 REYATAZ r arm 65 angiotensin converting enzyme inhibitors 65 rituximab Rituxan ® 65 liposomal doxorubicin 65 noninferior 65 metastatic pancreatic 65 irinotecan 65 ribavirin USP 65 raltegravir 65 LVEF 64 docetaxel Taxotere R 64 zonisamide SR 64 achieved statistical significance 64 bortezomib refractory 64 VIRAMUNE 64 splenectomized 64 Femara letrozole 64 GVAX 64 unresectable tumors 64 dose clopidogrel 64 evaluable subjects 64 locoregional disease 64 NAVISTAR R 64 nondiabetic patients 64 potent CYP#A# inhibitors 64 RSR# efaproxiral 64 APTIVUS 64 DFMO 64 AVELOX 64 mcg dose 64 tipranavir ritonavir 64 leucovorin 64 chemotherapeutic regimens 64 intermittent dosing 64 REMICADE monotherapy 64 enalapril 64 refractory chronic lymphocytic 64 CRp 64 prospectively stratified 64 LT NS# 64 + PH# 64 Cetuximab 64 sirolimus stent 64 receiving golimumab 64 ancrod 64 mg administered orally 64 Mitoxantrone 64 MADRS score 64 Targretin capsules 64 bortezomib Velcade 64 external beam radiotherapy 64 AGILECT R 64 bortezomib Velcade R 64 PROMACTA 64 cytoreductive surgery 64 Raptiva r 64 Degarelix 64 Temsirolimus 64 biliary tract cancer 64 RGT arm 64 liposome injection 64 PEG interferon 64 risedronate 64 completely resected 64 allopurinol 64 definite stent thrombosis 64 pyridostigmine 64 desvenlafaxine succinate 64 glycoprotein IIb IIIa inhibitor 64 receiving INTRON 64 metastatic hormone refractory 64 relapsed ovarian cancer 64 BRIM2 64 Tamibarotene 64 Newly Diagnosed Multiple Myeloma 64 trastuzumab Herceptin ® 64 Mg Uk 64 drotrecogin alfa activated 64 CsA 64 IFN beta 64 BoNTA 64 Bortezomib 64 sirolimus eluting stents 64 dabigatran etexilate 64 pT3 64 sipuleucel T 64 lipid lowering agents 64 rFSH 64 epoetin alfa 64 forodesine 64 IV bolus 64 cisplatin 64 locoregional control 64 clinically localized prostate 64 aprepitant 64 tiotropium bromide 64 arterial thromboembolic events 64 FFR guided treatment 64 GOUT 64 5 FU 64 PEG IFN 64 REVLIMID ® 64 Elotuzumab 64 carboplatin chemotherapy 64 Lenalidomide 64 KRAS status 64 #mg/day [001] 64 ceftriaxone 64 undergone radical prostatectomy 64 mycophenolate mofetil MMF 64 aflibercept 64 oral vancomycin 64 evaluable 64 micafungin 64 Vidaza ® 64 hepatic metastases 64 mL/min/#.# m 2 64 hepatorenal syndrome 64 cidofovir 64 complete cytogenetic 64 TYGACIL 64 adjuvant tamoxifen 64 AEGR 64 Patients Treated With 64 dosing cohorts 64 measurable tumor regressions 64 fallopian tube cancers 64 #mg BID [003] 64 Ramipril 64 Fludara ® 64 bivalirudin monotherapy 64 NovoTTF 64 crizotinib PF # 64 generalized edema 64 Randomized Phase 64 Angiomax monotherapy 64 revascularizations 64 CD3 monoclonal antibody 64 basal bolus regimen 64 plasma uric acid 64 Medoxomil 64 ALVESCO 64 underwent liver transplantation 64 pegaptanib 64 triamcinolone 64 INVEGA ® 64 lanthanum carbonate 64 epoprostenol 64 antiarrhythmic drug 64 custirsen 64 receptor tyrosine kinase inhibitor 64 TDF FTC 64 haematologic 64 WBRT 64 q8h 64 insulin lispro 64 Non inferiority 64 thiazide diuretic 64 iloprost 64 ezetimibe simvastatin 64 QTc prolongation 64 intravenous bolus 64 revascularization procedures 64 Q2W 64 LEXIVA 64 randomized multicenter Phase III 64 intravesical infusion therapy 64 Tarceva erlotinib 64 infliximab 64 gastrointestinal stromal tumors GIST 64 stage IIIb 64 heavily pretreated 64 GLIADEL R Wafer 64 antifibrinolytic 64 mg Proellex 64 elotuzumab 64 PREMPRO 64 administered subcutaneously 64 paricalcitol 64 remission induction 64 Proleukin 64 elagolix 64 Eltrombopag 64 dosing cohort 64 ischemic cardiomyopathy 64 perioperative mortality 64 mcg Albuferon 64 sevelamer 64 unresectable HCC 64 YONDELIS 64 Epoetin alfa 64 ramipril 64 FOLFOX6 chemotherapy regimen 64 hypokalemia 64 1mg 2mg 64 Ziprasidone 64 HoLEP 64 gemtuzumab ozogamicin 64 regorafenib 64 TAXUS Liberte Long 64 levofloxacin 64 recurrent metastatic 64 XGEVA 64 mCRC 64 ug kg 64 Viread Emtriva 64 ACE inhibitor ramipril 64 K ras mutations 64 QTcF 64 colectomy 64 Seliciclib 64 lipid lowering therapy 64 baminercept 64 simvastatin ezetimibe 64 MoxDuo TM IR 64 EXJADE 64 baseline LDH 64 non metastatic osteosarcoma 64 undetectable HBV DNA 64 tinidazole 64 biologic therapy 64 RAPAFLO 64 darunavir r 64 adefovir treated 64 AZT zidovudine Retrovir 64 bosutinib 64 relapsing multiple sclerosis 64 mg RDEA# 64 sorafenib tablets 64 moderately emetogenic 64 neoadjuvant treatment 64 recurrent glioblastoma 64 rituximab 64 darbepoetin alfa 64 otamixaban 64 systemic corticosteroid 64 antihypertensive therapy 64 Tocilizumab 64 non squamous 64 rituximab refractory 64 azilsartan medoxomil 64 receiving VELCADE 64 gastrointestinal toxicities 63 mg hydrochlorothiazide 63 terlipressin